TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis

MLA

H, Yoshizawa, et al. “TGF-Β₁-SiRNA Delivery with Nanoparticles Inhibits Peritoneal Fibrosis.” Gene Therapy, vol. 22, no. 4, Apr. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........df65fad80e671779791db1f0d0ff4031&authtype=sso&custid=ns315887.

APA

H, Y., Y, M., M, W., K, I., S, M., E, K., & D, N. (2014). TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis. Gene Therapy, 22(4).

Chicago

H, Yoshizawa, Morishita Y, Watanabe M, Ishibashi K, Muto S, Kusano E, and Nagata D. 2014. “TGF-Β₁-SiRNA Delivery with Nanoparticles Inhibits Peritoneal Fibrosis.” Gene Therapy 22 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........df65fad80e671779791db1f0d0ff4031&authtype=sso&custid=ns315887.